Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1985 Nov;121(2):316–321.

Role of alpha 1-adrenoceptors in norepinephrine-induced cardiomyopathy.

J C Lee, D P Sponenberg
PMCID: PMC1888062  PMID: 2998193

Abstract

This study practically delineated the contribution of alpha-adrenoceptor activation to the pathogenesis of norepinephrine (NE) cardiomyopathy. A total of 64 adult New Zealand white rabbits were used. NE cardiomyopathy was produced in rabbits by a 90-minute intravenous infusion of norepinephrine (2 micrograms/kg/min at infusion rate 0.382 ml/min). Arterial blood pressure and heart rate were constantly monitored. Arterial blood samples were obtained at 30-minute intervals for measurements of pH, blood gases, and glucose. Alpha-adrenoceptor blocking agents, when employed, were given 15 minutes prior to the initiation of NE infusion. Two days after treatment the rabbits were killed. The hearts were examined microscopically and assigned a histologic score. Pretreatment with the alpha 1-adrenoceptor blocker prazosin at 50, 100, or 200 micrograms/kg significantly reduced NE-induced myocardial injury in a dose-related manner. In contrast, the presence of alpha 2-adrenoceptor blocker yohimbine at 2.5 or 5.0 mg/kg was ineffective in preventing the formation of myocardial lesions. These findings suggest that NE cardiomyopathy may result largely from activation of the alpha 1-adrenoceptor system in the rabbit model.

Full text

PDF
316

Images in this article

317Figure 1
on p.317

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atlas D., Adler M. alpha-adrenergic antagonists as possible calcium channel inhibitors. Proc Natl Acad Sci U S A. 1981 Feb;78(2):1237–1241. doi: 10.1073/pnas.78.2.1237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Berthelsen S., Pettinger W. A. A functional basis for classification of alpha-adrenergic receptors. Life Sci. 1977 Sep 1;21(5):595–606. doi: 10.1016/0024-3205(77)90066-2. [DOI] [PubMed] [Google Scholar]
  3. Bloom S., Davis D. L. Calcium as mediator of isoproterenol-induced myocardial necrosis. Am J Pathol. 1972 Dec;69(3):459–470. [PMC free article] [PubMed] [Google Scholar]
  4. Downing S. E., Lee J. C. Contribution of alpha-adrenoceptor activation to the pathogenesis of norepinephrine cardiomyopathy. Circ Res. 1983 Apr;52(4):471–478. doi: 10.1161/01.res.52.4.471. [DOI] [PubMed] [Google Scholar]
  5. Downing S. E., Lee J. C. Effects of insulin on experimental catecholamine cardiomyopathy. Am J Pathol. 1978 Nov;93(2):339–352. [PMC free article] [PubMed] [Google Scholar]
  6. Drew G. M., Whiting S. B. Evidence for two distinct types of postsynaptic alpha-adrenoceptor in vascular smooth muscle in vivo. Br J Pharmacol. 1979 Oct;67(2):207–215. doi: 10.1111/j.1476-5381.1979.tb08668.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Exton J. H. Molecular mechanisms involved in alpha-adrenergic responses. Mol Cell Endocrinol. 1981 Sep;23(3):233–264. doi: 10.1016/0303-7207(81)90123-4. [DOI] [PubMed] [Google Scholar]
  8. Fain J. N., García-Sáinz J. A. Role of phosphatidylinositol turnover in alpha 1 and of adenylate cyclase inhibition in alpha 2 effects of catecholamines. Life Sci. 1980 Apr 14;26(15):1183–1194. doi: 10.1016/0024-3205(80)90062-4. [DOI] [PubMed] [Google Scholar]
  9. Ferrans V. J., Hibbs R. G., Walsh J. J., Burch G. E. Histochemical and electron microscopical studies on the cardiac necroses produced by sympathomimetic agents. Ann N Y Acad Sci. 1969 Jan 31;156(1):309–332. doi: 10.1111/j.1749-6632.1969.tb16737.x. [DOI] [PubMed] [Google Scholar]
  10. Glossmann H., Hornung R. Calcium- and potassium-channel blockers interact with alpha-adrenoceptors. Mol Cell Endocrinol. 1980 Sep;19(3):243–251. doi: 10.1016/0303-7207(80)90054-4. [DOI] [PubMed] [Google Scholar]
  11. Godfraind T. Calcium exchange in vascular smooth muscle, action of noradrenaline and lanthanum. J Physiol. 1976 Aug;260(1):21–35. doi: 10.1113/jphysiol.1976.sp011501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Guicheney P., Garay R. P., Levy-Marchal C., Meyer P. Biochemical evidence for presynaptic and postsynaptic alpha-adrenoceptors in rat heart membranes: positive homotropic cooperativity of presynaptic binding. Proc Natl Acad Sci U S A. 1978 Dec;75(12):6285–6289. doi: 10.1073/pnas.75.12.6285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Haft J. I. Cardiovascular injury induced by sympathetic catecholamines. Prog Cardiovasc Dis. 1974 Jul-Aug;17(1):73–86. doi: 10.1016/0033-0620(74)90039-5. [DOI] [PubMed] [Google Scholar]
  14. Langer S. Z. Presynaptic regulation of catecholamine release. Biochem Pharmacol. 1974 Jul 1;23(13):1793–1800. doi: 10.1016/0006-2952(74)90187-7. [DOI] [PubMed] [Google Scholar]
  15. Langer S. Z. Sixth gaddum memorial lecture, National Institute for Medical Research, Mill Hill, January 1977. Presynaptic receptors and their role in the regulation of transmitter release. Br J Pharmacol. 1977 Aug;60(4):481–497. doi: 10.1111/j.1476-5381.1977.tb07526.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lee J. C., Downing S. E. Ventricular function in norepinephrine-induced cardiomyopathic rabbits. Am J Physiol. 1982 Feb;242(2):H191–H196. doi: 10.1152/ajpheart.1982.242.2.H191. [DOI] [PubMed] [Google Scholar]
  17. Lee J. C., Fripp R. R., Downing S. E. Myocardial responses to alpha-adrenoceptor stimulation with methoxamine hydrochloride in lambs. Am J Physiol. 1982 Mar;242(3):H405–H410. doi: 10.1152/ajpheart.1982.242.3.H405. [DOI] [PubMed] [Google Scholar]
  18. Lee J. Y., Walsh G. M., Heilman R. D., Radzialowski F. M. Differential blocking effects of prazosin and yohimbine on vasopressor responses to sympathetic nerve stimulation and intravenous norepinephrine in the pithed rat. Res Commun Chem Pathol Pharmacol. 1984 Jan;43(1):97–112. [PubMed] [Google Scholar]
  19. Lehr D., Krukowski M., Chau R. Acute myocardial injury produced by sympathomimetic amines. Isr J Med Sci. 1969 Jul-Aug;5(4):519–524. [PubMed] [Google Scholar]
  20. RONA G., KAHN D. S., CHAPPEL C. I. STUDIES ON INFARCT-LIKE MYOCARDIAL NECROSIS PRODUCED BY ISOPROTERENOL: A REVIEW. Rev Can Biol. 1963 Jun;22:241–255. [PubMed] [Google Scholar]
  21. Rabinowitz B., Chuck L., Kligerman M., Parmley W. W. Positive inotropic effects of methoxamine: evidence for alpha-adrenergic receptors in ventricular myocardium. Am J Physiol. 1975 Sep;229(3):582–585. doi: 10.1152/ajplegacy.1975.229.3.582. [DOI] [PubMed] [Google Scholar]
  22. SZAKACS J. E., CANNON A. L-Norepinephrine myocarditis. Am J Clin Pathol. 1958 Nov;30(5):425–434. doi: 10.1093/ajcp/30.5.425. [DOI] [PubMed] [Google Scholar]
  23. Schenk E. A., Moss A. J. Cardiovascular effects of sustained norepinephrine infusions. II. Morphology. Circ Res. 1966 May;18(5):605–615. doi: 10.1161/01.res.18.5.605. [DOI] [PubMed] [Google Scholar]
  24. Schümann H. J., Endoh S., Brodde O. E. The time course of the effects of beta- and alpha-adrenoceptor stimulation by isoprenaline and methoxamine on the contractile force and cAMP level of the isolated rabbit papillary muscle. Naunyn Schmiedebergs Arch Pharmacol. 1975;289(3):291–302. doi: 10.1007/BF00499982. [DOI] [PubMed] [Google Scholar]
  25. Sharma A. D., Saffitz J. E., Lee B. I., Sobel B. E., Corr P. B. Alpha adrenergic-mediated accumulation of calcium in reperfused myocardium. J Clin Invest. 1983 Sep;72(3):802–818. doi: 10.1172/JCI111051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Sheridan D. J., Penkoske P. A., Sobel B. E., Corr P. B. Alpha adrenergic contributions to dysrhythmia during myocardial ischemia and reperfusion in cats. J Clin Invest. 1980 Jan;65(1):161–171. doi: 10.1172/JCI109647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Simons M., Downing S. E. Coronary vasoconstriction and catecholamine cardiomyopathy. Am Heart J. 1985 Feb;109(2):297–304. doi: 10.1016/0002-8703(85)90597-6. [DOI] [PubMed] [Google Scholar]
  28. Singal P. K., Kapur N., Dhillon K. S., Beamish R. E., Dhalla N. S. Role of free radicals in catecholamine-induced cardiomyopathy. Can J Physiol Pharmacol. 1982 Nov;60(11):1390–1397. doi: 10.1139/y82-207. [DOI] [PubMed] [Google Scholar]
  29. Starke K. Alpha-adrenoceptor subclassification. Rev Physiol Biochem Pharmacol. 1981;88:199–236. [PubMed] [Google Scholar]
  30. Vatner S. F., Pagani M., Manders W. T., Pasipoularides A. D. Alpha adrenergic vasoconstriction and nitroglycerin vasodilation of large coronary arteries in the conscious dog. J Clin Invest. 1980 Jan;65(1):5–14. doi: 10.1172/JCI109659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Werner J. C., Lee J. C., Downing S. E. Preservation of left ventricular function by insulin in experimental catecholamine cardiomyopathy. Am J Physiol. 1980 Feb;238(2):H257–H262. doi: 10.1152/ajpheart.1980.238.2.H257. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES